Bumetanide, a drug already approved to treat swelling associated with conditions such as heart failure, improved performance on cognitive tests and reduced the buildup of amyloid plaques in mice with an Alzheimers-like condition, researchers report. Furthermore, in cultured human neurons derived from stem cells, bumetanide reversed gene expression changes associated with Alzheimers, and the electronic health records of millions of patients point to a link between the drug and reduced odds of being diagnosed with the disease.
On the basis of these results, published this week (October 10) in Nature Aging, Gladstone Institutes neurobiologist and study coauthor Yadong Huang tells STAT that he and his team are now pursuing a clinical trial to test the drug in human patients with at least one copy of the APOE4 variant, a well-known risk factor for the disease.
Bumetanide blocks ion channels in the cell membrane, thereby altering salt balances and reducing water retention, but how this mechanism might affect neural function is not known. The mechanism of the drug is well-known, but what the authors havent addressed is how that mechanism is related to what they think might happen if they were to give this drug to Alzheimers patients, Johns Hopkins University neurologist Shilpa Kadam, who was not involved in the study, tells STAT.
While bumetanide did shrink amyloid plaques in a mouse model of Alzheimers, the drug is not thought to target these protein aggregations directly as many experimental Alzheimers drugs have. Many such drugs have failed, and one that was recently approved, Biogens Aduhelm, has been mired in controversy, with some questioning its efficacy and the legitimacy of its regulatory review.
The new study supports a growing body of evidence that amyloid plaques are but one piece of the puzzle. In Alzheimers patients with at least one copy of APOE4, nearly 2,000 genes showed altered expression compared with healthy controls, Huang and his colleagues found. These included genes involved with circadian rhythms, morphine addiction, and the neurotransmitter GABA.
There are many cellular and molecular changes in Alzheimers disease patients besides plaques, but we usually dont talk about them, Huang tells STAT. He adds that patients may have different underlying cellular mechanisms that lead to their neurodegeneration, and thus may require different treatments. More and more people are accepting this concept, but its definitely still an emerging idea.
Jeffrey Cummings, director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada Las Vegas, tells STATthat the new study reveals a repertoire of pathways that have not been adequately investigated, but notes that bumetanide can cause dehydration and electrolyte imbalances. This drugs relationship to Alzheimers disease is not quite proven and its side effect profile is undesirable in older people, he says.
View post:
Repurposed Drug Reverses Signs of Alzheimers in Mice, Human Cells - The Scientist
- Carson City School District experiencing teacher shortage; nationwide data points to burnout, low pay and behavior issues as culprits - Carson Now - September 8th, 2022
- Get Healthy Carson City: Breastfeeding benefits a baby's health - Nevada Appeal - August 5th, 2022
- Promising solution to fatal genetic-disorder complications discovered by University professor and Ph.D. candidate - Nevada Today - July 19th, 2022
- Anosmia in COVID-19: Underlying Mechanisms and Assessment ... - November 22nd, 2021
- When aid-in-dying means you have to go before youre ready - Monterey Herald - August 31st, 2021
- BioRestorative Therapies Discusses Upcoming Annual Meeting - GlobeNewswire - August 18th, 2021
- Contrasting Mesoblast (NASDAQ:MESO) and Titan Pharmaceuticals (NASDAQ:TTNP) - Riverton Roll - February 2nd, 2020
- Nevada cancer survivor found to have two different sets of DNA after bone marrow transplant 4 years ago - MEAWW - January 20th, 2020
- Distinguished Efforts to Advance Science | The UCSB Current - The UCSB Current - November 28th, 2019
- Three Podcasts to Listen to in November - The New Yorker - November 5th, 2019
- Comparison of Spectrum Pharmaceuticals Inc. (SPPI) and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - MS Wkly - November 5th, 2019
- Spectrum Pharmaceuticals Inc. (SPPI) and TG Therapeutics Inc. (NASDAQ:TGTX) Comparison side by side - MS Wkly - October 15th, 2019
- Spectrum Pharmaceuticals Inc. (SPPI) and Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) Comparison side by side - CryptoCoinsTribune - September 22nd, 2019
- Stem Cell Therapy | Las Vegas, NV - September 10th, 2019
- Yolanda Hadids Lyme Disease Battle - Nevada Stem Cell ... - April 18th, 2019
- Regenerative Medicine Institute of Nevada RMinLasVegas ... - November 1st, 2018
- Las Vegas Stem Cells Treatment, Nevada, Legal, Reno, Mogul ... - September 24th, 2017
- New Face: Janice Pluth - UNLV NewsCenter - August 28th, 2017
- Cody Garbrandt Likely Won't Return Until at Least November - MMA News - July 7th, 2017
- Regenexx Las Vegas | Nevada's Regenexx Provider - July 6th, 2017
- Our Team - Stem Cell Therapy in Reno NV - July 6th, 2017
- Dynamic Stem Cell Therapy | Stem Cell Therapy Nevada - July 6th, 2017
- Stem Cell Therapy Reno NV - Sierra Stem Cell Institute - July 6th, 2017
- Digital Scholarship@UNLV - University of Nevada, Las Vegas - November 12th, 2016
- Regenerative Medicine | Nevada Pain - Las Vegas, Henderson - October 9th, 2016
- Facts About Abortion: Stem Cell Research and Abortion - October 19th, 2015
- Regenerative Cell Institute Las Vegas | Stem Cell Therapy ... - July 2nd, 2015
- Stem Cell Therapies News - World Stem Cells, LLC - March 13th, 2015
- Experimental research turns out well for local man - November 5th, 2014
- An update review of stem cell applications in burns and ... - October 27th, 2014
- Portola volunteer firefighter battles leukemia - October 24th, 2014
- vegas | The Stem Cell Blog - September 29th, 2014
- Stem-Cell Therapy and Repair after Heart Attack and Heart ... - September 27th, 2014
- 11. Use of Genetically Modified Stem Cells in Experimental ... - September 27th, 2014
- Dr. Foulk - Welcome to Nevada Center for Reproductive Medicine - September 27th, 2014
- Patients guide to treatments | Knoepfler Lab Stem Cell Blog - September 27th, 2014
- Nevada Stem Cell Treatment | Stem Cell Treatments - September 7th, 2014
- Stem Cell Therapy News, Stories | Regenerative Medicine ... - August 29th, 2014
- Nevada (Stem Cell) - what-when-how - August 22nd, 2014